Smad3-Targeted Therapy Protects against Cisplatin-Induced AKI by Attenuating Programmed Cell Death and Inflammation via a NOX4-Dependent Mechanism.
Kidney Dis (Basel)
; 7(5): 372-390, 2021 Sep.
Article
in En
| MEDLINE
| ID: mdl-34604344
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
/
Prognostic_studies
Language:
En
Journal:
Kidney Dis (Basel)
Year:
2021
Document type:
Article
Affiliation country:
China
Country of publication:
Suiza